These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4566780)

  • 1. Techniques of in vivo plasma modification for the treatment of hyperacute rejection.
    Shons AR; Bier M; Jetzer T; Najarian JS
    Surgery; 1973 Jan; 73(1):28-37. PubMed ID: 4566780
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental xenografting in widely divergent species. Modification of the hyperacute xenogeneic rejection of kidneys from pigs (donor) by extreme hemodilution of dogs (recipients) (author's transl)].
    Fiedler L; Hammer C; Messmer K; Land W; Holper K; Klövekorn W; Pielsticker K; Chaussy C; Brendel W
    Res Exp Med (Berl); 1974 Jun; 163(2):137-53. PubMed ID: 4136361
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolongation of renal xenografts by the simultaneous sequestration of preformed antibody, inhibition of complement, coagulation and antibody synthesis.
    Moberg AW; Shons AR; Gewurz H; Mozes M; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):538-41. PubMed ID: 4937935
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolongation of heterograft survival by electrophoretic extraction of preformed antibody.
    Shons AR; Jetzer T; Moberg AW; Najarian JS
    Surg Forum; 1970; 21():263-5. PubMed ID: 4105884
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of xenoantibody and formed cellular blood elements on ex vivo xenograft hyperacute rejection.
    Han LK; Henry ML; Ferguson RM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):574-5. PubMed ID: 1990612
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of leukocytes and lysosomal enzymes in antibody-mediated (hyperacute) rejection of renal heterografts.
    Palutke M; Kihn R; Perry M; Riddle J; Rector F; Rosenberg JC
    Lab Invest; 1972 Sep; 27(3):287-95. PubMed ID: 4341548
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathogenesis of hyperacute rejection of homo- and heterotransplants of the kidney in dogs].
    Böhmig HJ
    Wien Klin Wochenschr; 1971 Jun; 83(24):429-36. PubMed ID: 4399511
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet survival in rabbits to detect hyperacute rejection.
    Andersen O; Tissot R; Cohen C; Jonasson O
    J Surg Res; 1973 Mar; 14(3):193-9. PubMed ID: 4573854
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of xenograft hyperacute rejection via xenoantibody depletion.
    Henry ML; Han LK; Orosz CG; Sedmak D; Ferguson RM
    Transplant Proc; 1990 Jun; 22(3):1081-2. PubMed ID: 2349665
    [No Abstract]   [Full Text] [Related]  

  • 10. [The complement system in experimental and clinical kidney transplantation (author's transl)].
    Kux M
    Wien Klin Wochenschr; 1974 Jan; 86(2):29-39. PubMed ID: 4613019
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperacute kidney graft rejection with and without demonstration of antibodies].
    Kux M
    Chirurg; 1975 Jun; 46(6):262-7. PubMed ID: 1102270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenograft rejection by dog and man: isolated kidney perfusion with blood and plasma.
    Mozes MF; Gewurz H; Gunnarson A; Moberg AW; Westberg NG; Jetzer T; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):531-3. PubMed ID: 4937933
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphologic study of the participation of the complement system in hyperacute rejection of renal xenotransplants.
    Mejĩa-Laguna JE; Martĩnez-Palomo A; Biro CE; Chãvez B; Lõpez-Soriano F; Carcĩa-Cornejo M
    Am J Pathol; 1972 Oct; 69(1):71-8. PubMed ID: 4562798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal xenografts perfused ex vivo require both humoral and cellular components to undergo hyperacute rejection.
    Bryan BA; Henry ML; Ferguson RM
    Transplant Proc; 1992 Apr; 24(2):609. PubMed ID: 1566449
    [No Abstract]   [Full Text] [Related]  

  • 15. Dominant role of complement in the hyperacute xenograft rejection reaction.
    Schilling A; Land W; Pratschke E; Pielsticker K; Brendel W
    Surg Gynecol Obstet; 1976 Jan; 142(1):29-32. PubMed ID: 1105839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of hyperactue xenogeneic kidney rejection.
    Messmer K; Hammer C; Land W; Fiedler L; Klövekorn WP; Holper K; Lob G; Merzel D; Brendel W
    Transplant Proc; 1971 Mar; 3(1):542-4. PubMed ID: 4937936
    [No Abstract]   [Full Text] [Related]  

  • 17. Delay of xenograft rejection through oxidation of blood during hemodialysis.
    Bier M; Zukoski F; Boyer JT; Beavers CD; Merriman WG
    Trans Am Soc Artif Intern Organs; 1971; 17():64-74. PubMed ID: 4945714
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro studies on the mechanism of hyperacute xenograft rejection.
    Land W; Schilling A; Aldenhoff J; Lamerz R; Pielsticker K; Mendler N; Brendel W
    Transplant Proc; 1971 Mar; 3(1):888-90. PubMed ID: 4937986
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental xenografting in widely divergent species. Modification of the hyperacute rejection by pretreatment of dogs (recipient) with soluble liver antigens from pigs (donors)].
    Land W; Hammer C; Fiedler L; Brendel W
    Res Exp Med (Berl); 1972; 158(1):1-22. PubMed ID: 4559679
    [No Abstract]   [Full Text] [Related]  

  • 20. Rejection: the major problem of organ transplantation in man and animals.
    Dalton RG
    Vet Rec; 1974 Apr; 94(15):333-6. PubMed ID: 4599402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.